Injectable HIV treatment offers hope to Ugandan patients
The treatment, developed by British drugmaker GlaxoSmithKline, is the first non-pill option against HIV, and studies have shown it even outperforms the efficacy of oral pills
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.